Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sybil Hosek

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Trials|July 27, 2021
The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocolAndrew Medina-Marino, Dana Bezuidenhout, Sybil Hosek, et al.
Plos One|April 13, 2022
Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trialJennifer Velloza, Nicole Poovan, Nontokozo Ndlovu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC StudyAlbert Y Liu, Eric Vittinghoff, Patricia von Felten, et al.
The Lancet. HIV|December 16, 2024
Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trialJennifer Velloza, Nicole Poovan, Allison Meisner, et al.
AIDS and Behavior|June 2, 2025
Motivations for Starting and Stopping PrEP: Experiences of Adolescent Girls and Young Women in the HPTN 082 TrialLisa Mills, Makhosazane Nomhle Ndimande-Khoza, Jennifer Velloza, et al.
AIDS and Behavior|April 30, 2016
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyMegha L Mehrotra, David V Glidden, Vanessa McMahan, et al.
The Lancet. HIV|September 24, 2016
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort studyMonica Gandhi, David V Glidden, Kenneth Mayer, et al.
Journal of the International AIDS Society|March 8, 2020
The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative studyJennifer Velloza, Nomhle Khoza, Fiona Scorgie, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Trials|July 27, 2021
The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocolAndrew Medina-Marino, Dana Bezuidenhout, Sybil Hosek, et al.
Plos One|April 13, 2022
Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trialJennifer Velloza, Nicole Poovan, Nontokozo Ndlovu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC StudyAlbert Y Liu, Eric Vittinghoff, Patricia von Felten, et al.
The Lancet. HIV|December 16, 2024
Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trialJennifer Velloza, Nicole Poovan, Allison Meisner, et al.
AIDS and Behavior|June 2, 2025
Motivations for Starting and Stopping PrEP: Experiences of Adolescent Girls and Young Women in the HPTN 082 TrialLisa Mills, Makhosazane Nomhle Ndimande-Khoza, Jennifer Velloza, et al.
AIDS and Behavior|April 30, 2016
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyMegha L Mehrotra, David V Glidden, Vanessa McMahan, et al.
The Lancet. HIV|September 24, 2016
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort studyMonica Gandhi, David V Glidden, Kenneth Mayer, et al.
Journal of the International AIDS Society|March 8, 2020
The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative studyJennifer Velloza, Nomhle Khoza, Fiona Scorgie, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
Pageof 9